General Biologicals Corporation (TPEX:4117)
Taiwan · Delayed Price · Currency is TWD 8.36
-0.13 (-1.53%)
Sep 30, 2026, 1:50 PM CST
General Biologicals Market Cap
General Biologicals has a market cap or net worth of 601.02 million as of September 29, 2026. Its market cap has decreased by -37.46% in one year.
Market Cap
601.02M
Enterprise Value
2.53B
Revenue
260.23M
Ranking
n/a
PE Ratio
1.11
Stock Price
8.36
ChartMarket Cap Chart
Since February 21, 2005, General Biologicals's market cap has increased from 326.98M to 601.02M, an increase of 83.81%. That is a compound annual growth rate of 2.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 601.02M | -23.10% |
| Dec 31, 2025 | 781.59M | -38.66% |
| Dec 31, 2024 | 1.27B | -21.11% |
| Dec 29, 2023 | 1.62B | 0.37% |
| Dec 30, 2022 | 1.61B | -22.70% |
| Dec 30, 2021 | 2.08B | -35.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InnoPharmax | 1.28B |
| GeneFerm Biotechnology | 1.22B |
| Excelsior Biopharma | 1.09B |
| Anxo Pharmaceutical | 1.07B |
| Prince Pharmaceutical | 1.07B |
| DV Biomed | 989.79M |
| Original BioMedicals | 851.80M |
| Winston Medical Supply | 823.24M |